476 related articles for article (PubMed ID: 19408504)
1. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
[TBL] [Abstract][Full Text] [Related]
2. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Ménière's disease by intratympanic gentamicin application.
Assimakopoulos D; Patrikakos G
J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
7. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
8. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
9. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
Carey J
Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
12. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
Corsten M; Marsan J; Schramm D; Robichaud J
J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
[TBL] [Abstract][Full Text] [Related]
13. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
Crane BT; Minor LB; Della Santina CC; Carey JP
Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
[TBL] [Abstract][Full Text] [Related]
14. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
Ganança MM; Caovilla HH; Ganança FF
Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
Smith WK; Sandooram D; Prinsley PR
J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
Atlas JT; Parnes LS
Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
[TBL] [Abstract][Full Text] [Related]
18. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
19. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
20. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
Büki B; Platz M; Haslwanter T; Jünger H; Avan P
Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
